SEC Form 4 · accession 0001645627-17-000091
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 7, 2017
Accepted (ET)
Jul 11, 2017 · 12:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 7, 2017 | P | 5,000 | $0.0285 | A | 21,534,349 | D | |
| Common Stock | Jul 7, 2017 | P | 5,000 | $0.0299 | A | 21,539,349 | D |
Table II — derivative securities
No Table II lines on this filing.